Patent directory · USPTO A61K / A61P
Patents matching “Ionis Pharmaceuticals, Inc.”
202 pharma patents match "Ionis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 202 pharmaceutical patents matching "Ionis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9677076
Modulation of hepatitis B virus (HBV) expression
granted -
US 9670492
Modulation of prekallikrein (PKK) expression
granted -
US 9663783
Modulation of alpha synuclein expression
granted -
US 9650636
Methods for treating hypercholesterolemia
granted -
US 9644207
Compositions and methods for modulating Tau expression
granted -
US 9624496
Modulation of apolipoprotein C-III expression
granted -
US 9617539
Modulation of UBE3A-ATS expression
granted -
US 9617540
Compounds and methods for modulating gene expression
granted -
US 9605259
Compounds and methods for modulating protein expression
granted -
US 9605263
Compositions for modulating C9ORF72 expression
granted -
US 9598693
Oligomeric compounds and compositions for the use in modulation of micrornas
granted -
US 9593333
Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations
granted -
US 9574193
Methods and compositions for modulating apolipoprotein (a) expression
granted -
US 9567588
Modulation of androgen receptor expression
granted -
US 9567587
Antisense modulation of GCCR expression
granted -
US 9550988
Antisense compounds
granted -
US 9546368
Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression
granted -
US 9540641
Cancer treatment
granted -
US 9523094
Methods of treating kennedy's disease
granted -
US 9518259
Compounds and methods for modulating interaction between proteins and target nucleic acids
granted -
US 9487780
Antisense compounds targeting genes associated with fibronectin
granted -
US 9476051
Antisense modulation of superoxide dismutase 1, soluble expression
granted -
US 9428750
Oligomeric compounds comprising tricyclic nucleosides and methods for their use
granted -
US 9409934
Cyclohexenyl nucleic acids analogs
granted